CT001

DRUG4 trials

Sponsors

Cessatech A/S

Conditions

AnalgesiaBioavailabilityPain

Phase 1

Study of CT001 in Healthy Volunteers

CompletedNCT04807335

Cessatech A/SBioavailability

Start: 2021-03-17End: 2021-06-02Updated: 2021-08-24

Phase 2

Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures

CompletedNCT04897750

Cessatech A/SAnalgesia

Start: 2021-08-19End: 2022-05-16Updated: 2022-08-18

Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001

CompletedNCT05508594

Cessatech A/SPain

Start: 2022-09-05End: 2023-10-05Updated: 2023-10-18

Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric Patients

CompletedNCT06364072

Cessatech A/SPain

Start: 2024-05-27End: 2025-05-09Updated: 2026-02-02